The use of software that blocks ads hinders our ability to serve you the content you came here to enjoy. We ask that you ...

To opt-out click on “Do Not Sell or Share My Personal Information” in the website footer, or to learn more, please visit our privacy policy.

Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

Maryland is reviving plans to expand MARC, its regional rail service, into Delaware and Virginia and add more trains every ...

From Nobel laureates to AI-driven research, the Wilmer Eye Institute honors a century of transforming vision science and care ...

“Poor notes negatively impact patient care,” wrote the authors of a new study conducted at Johns Hopkins, Baltimore, and published in the ... Refusing to accept that, Johns Hopkins’ Samuel Durso, MD, ...

A novel PET radiotracer can accurately detect a wide range of mold species that are linked to dangerous infections, according ...

The CATALYST meta-analysis pooled the four studies and identified 5,441 people with acute ischemic stroke and Afib for ...

Aclarion has enrolled its first patients in a clinical trial designed to reduce back pain at the Texas Back Institute in Plano. The chronic low back pain randomized independent trial study (CLARITY) ...

Dr. Nadine Caron, a professor at the University Hospital of Northern British Columbia (UHNBC), was one of six Canadians ...